Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis.

R Bergamaschi1, C Berzuini, A Romani

  • 1Neurological Institute Fondazione C. Mondino, via Palestro 3, 27100 Pavia, Italy. roberto.bergamaschi@mondino.it

Journal of the Neurological Sciences
|September 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sociodemographic profile, health-related behaviours and experiences of healthcare access in Italian transgender and gender diverse adult population.

Journal of endocrinological investigation·2024
Same author

Estimate and needs of the transgender adult population: the SPoT study.

Journal of endocrinological investigation·2024
Same author

Search for Dark-Matter-Nucleon Interactions via Migdal Effect with DarkSide-50.

Physical review letters·2023
Same author

Search for Dark Matter Particle Interactions with Electron Final States with DarkSide-50.

Physical review letters·2023
Same author

Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI).

Journal of endocrinological investigation·2022
Same author

Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment.

Journal of endocrinological investigation·2022
Same journal

Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

Journal of the neurological sciences·2026
Same journal

Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

Journal of the neurological sciences·2026
Same journal

Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

Journal of the neurological sciences·2026
Same journal

Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

Journal of the neurological sciences·2026
Same journal

Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

Journal of the neurological sciences·2026
Same journal

Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

Journal of the neurological sciences·2026
See all related articles

This study identifies early clinical signs that predict long-term Multiple Sclerosis (MS) progression. Key predictors include age, neurological involvement, and specific symptoms, aiding in early intervention for relapsing remitting MS patients.

Area of Science:

  • Neurology
  • Biostatistics
  • Clinical Epidemiology

Background:

  • Relapsing-remitting Multiple Sclerosis (MS) is a chronic neurological disease.
  • Predicting the long-term course, particularly progression to secondary progressive MS, is crucial for patient management.
  • Early identification of prognostic factors can improve clinical trial design and patient outcomes.

Purpose of the Study:

  • To develop a Bayesian statistical model to identify short-term clinical predictors of long-term Multiple Sclerosis (MS) disease evolution.
  • To focus on predicting the onset of secondary progressive MS using early-stage patient data.
  • To assess the accuracy and reliability of early indicators in predicting disease failure.

Main Methods:

  • Utilized a Bayesian statistical model to analyze the natural course of relapsing-remitting MS.

Related Experiment Videos

  • Modeled the full joint probability distribution of early indicators, intermediate indicators, and time to failure.
  • Incorporated longitudinal data from 186 MS patients, treating intermediate indicators as surrogate response events for right-censored data.

    • Main Results:

    • Identified key early predictors of disease progression: age, number of neurological functional systems (FSs) involved, sphincter/motor/motor-sensory symptoms, and presence of sequelae.
    • Found that reaching an Expanded Disability Status Scale (EDSS) score of 4 or more outside of relapse, experiencing sphincter or motor relapses, and moderate pyramidal involvement within the first 3 years were unfavorable prognostic factors.

    Conclusions:

    • The developed Bayesian model accurately predicts long-term MS progression using early clinical indicators.
    • Identified specific short-term manifestations as strong predictors of long-term disease evolution, valuable for clinical trials.
    • Highlights the importance of early assessment of specific symptoms and disability metrics for risk stratification in MS patients.